tetano
Editor, Senior Moderator
Acta Virol. 2011;55(2):147-53.
Overexpression of α-2,6 sialyltransferase stimulates propagation of human influenza viruses in Vero cells.
Li N, Qi Y, Zhang FY, Yu XH, Wu YG, Chen Y, Jiang CL, Kong W.
Abstract
Human influenza viruses are major concern as the leading cause of global pandemics. In infecting cells, they preferentially bind to sialyloligosaccharides containing terminal N-acetyl sialic acid linked to galactose by an α-2,6-linkage (NeuAcα2,6Gal). The amount of NeuAcα2,6Gal in Vero cells, which are predominantly used for production of influenza vaccines over the past 30 years, may not be as high as that in epithelial cells of human respiratory tract, what leads to the suboptimal virus growth in Vero cells. In this study, we stably transfected Vero cells with cDNA of human α-2,6-sialyltransferase (SIAT1), an enzyme catalyzing α-2,6-sialylation of galactose on glycoproteins. Overexpression of SIAT1 in the transfected Vero cells (Vero-SIAT1 cells) was confirmed by Western blot analysis and immunofluorescence microscopy. Vero-SIAT1 cells expressed 7 times higher amounts of NeuAcα2,6Gal, but 3 times lower amounts of NeuAcα2,3Gal as compared to parental Vero cells. Furthermore, the influenza viruses A (H1N1 and H3N2) and B grew in Vero-SIAT1 cells to the higher titers than in Vero cells. Taken together, these results imply that Vero-SIAT1 cells are useful not only for the propagation of human influenza viruses, but also for the preparation of influenza vaccines. Keywords: influenza virus; α-2,6 sialyltransferase; Vero cells.
PMID:
21692563
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21692563
Overexpression of α-2,6 sialyltransferase stimulates propagation of human influenza viruses in Vero cells.
Li N, Qi Y, Zhang FY, Yu XH, Wu YG, Chen Y, Jiang CL, Kong W.
Abstract
Human influenza viruses are major concern as the leading cause of global pandemics. In infecting cells, they preferentially bind to sialyloligosaccharides containing terminal N-acetyl sialic acid linked to galactose by an α-2,6-linkage (NeuAcα2,6Gal). The amount of NeuAcα2,6Gal in Vero cells, which are predominantly used for production of influenza vaccines over the past 30 years, may not be as high as that in epithelial cells of human respiratory tract, what leads to the suboptimal virus growth in Vero cells. In this study, we stably transfected Vero cells with cDNA of human α-2,6-sialyltransferase (SIAT1), an enzyme catalyzing α-2,6-sialylation of galactose on glycoproteins. Overexpression of SIAT1 in the transfected Vero cells (Vero-SIAT1 cells) was confirmed by Western blot analysis and immunofluorescence microscopy. Vero-SIAT1 cells expressed 7 times higher amounts of NeuAcα2,6Gal, but 3 times lower amounts of NeuAcα2,3Gal as compared to parental Vero cells. Furthermore, the influenza viruses A (H1N1 and H3N2) and B grew in Vero-SIAT1 cells to the higher titers than in Vero cells. Taken together, these results imply that Vero-SIAT1 cells are useful not only for the propagation of human influenza viruses, but also for the preparation of influenza vaccines. Keywords: influenza virus; α-2,6 sialyltransferase; Vero cells.
PMID:
21692563
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/21692563